查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853992

癌症資訊系統市場按服務產品、功能、部署類型、應用和最終用戶分類－全球預測，2025-2032年

Oncology Information Systems Market by Offering, Functionality, Deployment Mode, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，癌症資訊系統市場規模將達到 134.2 億美元，複合年成長率為 7.78%。

關鍵市場統計數據
基準年2024年 73.7億美元
預計年份：2025年 79.1億美元
預測年份 2032 134.2億美元
複合年成長率 (%) 7.78%

在精準醫療、互通性要求和以病人為中心的數位化照護路徑驅動下，駕馭不斷變化的腫瘤學生態系統

癌症診療流程正受到技術、臨床和監管因素的重塑，這些因素對資訊管理提出了新的要求。醫護人員需要在日益複雜的治療方法與收集和整合多源臨床數據之間尋求平衡，因此，腫瘤資訊系統的角色正在從行政支援轉向策略基礎設施。在此背景下，領導者不僅需要了解產品功能，還需要了解系統如何整合診療路徑、支援多學科團隊並維持長期的互通性。

臨床醫生和管理人員目前都在尋求能夠減輕認知負荷、加快決策速度並實現腫瘤特定工作流程和企業IT資產之間無縫資料交換的平台。隨著精準腫瘤學的擴展，對能夠將化療管理、放射治療計劃、影像整合、實驗室數據和縱向電子健康記錄整合到統一用戶體驗中的解決方案的需求也日益成長。因此，那些展現出臨床療效、易於整合且能顯著提升病患安全和營運效率的系統，在投資決策中越來越受到重視。

本導言透過重點闡述這些趨勢對供應商、醫療系統和政策制定者的策略影響，為後續分析組裝。它指出了關鍵曲折點，探討了基於細分市場的產品策略的影響，並概述了領導者可以採取哪些立即行動，以使技術應用與以患者為中心的護理目標保持一致。

找出正在影響腫瘤學技術應用的變革性轉變，包括人工智慧診斷、雲端原生架構和臨床醫生工作流程重組。

癌症資訊系統領域正經歷一場變革性的轉變，其影響遠不止於產品功能的提升，而是涵蓋了全新的交付模式、分析範式和臨床工作流程。人工智慧和先進的視覺化技術正被引入臨床實踐，以提高診斷的準確性並輔助病例優先排序；同時，臨床決策支援系統正被深度融入治療計劃和排班流程，以減少治療方案的差異性並提高指南的依從性。同時，雲端原生技術的應用也在加速發展，使分散的團隊能夠存取統一的病患記錄，並實現臨床內容和法規遵循模組的快速更新。

互通性仍然是變革的核心。新的標準和應用程式介面（API）正在降低將實驗室資訊系統、影像檔案庫、放射治療計劃軟體和電子腫瘤病歷整合到統一的臨床流程中的門檻。這種轉變促使供應商採用模組化、API優先的架構，並尋求與臨床整合商和影像專家建立夥伴關係。臨床醫生期望獲得支援多學科協作的直覺使用者介面，而醫療系統則在培訓和變革管理方面投入資源，以確保技術的普及應用並切實提高患者安全。

總而言之，這些變更正在重新定義供應商的相關性和買家的期望。擁有強大的臨床檢驗、靈活的部署方案和清晰的實施藍圖的機構，最能支援不斷發展的醫療模式，並在臨床和營運方面實現可衡量的改善。

評估2025年美國關稅對腫瘤資訊系統供應鏈和服務的累積營運和採購影響

美國2025年關稅政策的實施，為腫瘤資訊系統供應商及其客戶的採購和供應鏈規劃帶來了新的變數。雖然軟體本身俱有可移植性，但涵蓋廣泛的腫瘤IT價值鏈還包括硬體、影像設備、專用伺服器和整合服務，這些都對貿易政策十分敏感。因此，關稅主導的成本壓力迫使採購團隊重新評估其供應商選擇、整體擁有成本以及設備和服務交付的緊急策略。

在營運方面，醫療系統和技術供應商已採取措施應對，包括分散供應商管道，並盡可能加快實體基礎設施的在地採購。這促使他們更加重視檢驗能夠最大限度減少對受關稅影響組件依賴的配置方案，最佳化虛擬化和雲端託管功能，並重新協商服務等級協定以應對潛在的供應延遲。同時，一些供應商調整了商業模式，透過提供配套服務、延長保固或組建本地安裝團隊來分擔部分增加的負擔。

關稅的影響遠不止於直接的採購策略；它也影響著圍繞製造在地化、合約靈活性和投資優先順序的策略討論。企業越來越重視供應鏈的韌性，將其納入供應商選擇標準，傾向選擇那些採購透明、物流能力強、緊急時應對計畫完善的合作夥伴。這些調整反映出產業普遍認知到，政策主導的成本動態會對部署進度、計劃利潤和營運風險產生重大影響。

將細分洞察轉化為可執行的產品和服務策略，涵蓋產品、功能、部署類型、應用程式和最終用戶群。

對市場區隔的深入理解對於使產品開發和市場推廣策略與臨床及營運需求保持一致至關重要。服務包括諮詢與培訓、安裝與整合以及維護與支持，而解決方案則包括化療資訊系統、臨床整合解決方案、實驗室資訊系統 (LIS)、醫學影像分析與高級視覺化、腫瘤電子健康記錄(EHR)、影像歸檔與通訊系統 (PACS) 和廠商中立歸檔系統 (VNA)、放射治療計劃系統以及影像放射資訊系統 (RIS)。這種雙重性凸顯了買家採購的是一系列功能和實施專業知識的組合，而非獨立的產品。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧驅動的預測分析整合到癌症資訊系統中，以實現個人化治療計劃。
  • 將全面的基因組序列資料整合到腫瘤智慧平台中，以實現精準醫療。
  • 雲端基礎的癌症資訊系統，可實現多學科護理團隊之間的安全遠端協作。
  • 實施 HL7 FHIR互通性標準，實現腫瘤數據無縫交換與報告
  • 先進的患者報告結果追蹤模組可提供癌症護理中生活品質的即時資訊。
  • 利用機器學習演算法，透過電子腫瘤記錄預測藥物不良反應，以改善安全監測。
  • 將遠距腫瘤虛擬醫療整合到癌症資訊系統中，以擴大農村患者的就醫途徑和支持。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 癌症資訊系統市場依產品/服務分類

  • 服務
    • 諮詢和培訓
    • 安裝與整合
    • 維護和支援
  • 解決方案
    • 化療資訊系統
    • 臨床整合解決方案
    • 實驗室資訊系統（LIS）
    • 醫療圖像分析與進階視覺化
    • 腫瘤電子健康紀錄（EHR）
    • 圖片歸檔與通訊系統 (PACS) 和廠商中立歸檔系統 (VNA)
    • 放射治療計劃系統
    • 放射資訊系統（RIS）

第9章 按功能分類的癌症資訊系統市場

  • 計費和收益周期管理
  • 臨床決策支持
  • 病人資訊和護理管理
  • 監理合規與報告
  • 治療計劃和安排

第10章 依部署模式分類的癌症資訊系統市場

  • 雲端基礎的
  • 本地部署

第11章 按應用分類的癌症資訊系統市場

  • 腫瘤內科
  • 放射腫瘤學
  • 外科腫瘤學

第12章 依最終用戶分類的癌症資訊系統市場

  • 消融和癌症護理中心
  • 醫院和診斷影像中心
  • 研究設施

第13章 各地區癌症資訊系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 癌症資訊系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國癌症資訊系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Accuray Incorporated
    • Advanced Data Systems Corporation
    • CompuGroup Medical, Inc.
    • CureMD.com, Inc.
    • DOSIsoft SA
    • Elekta AB
    • EndoSoft LLC by Utech Products Inc.
    • Epic Systems Corporation
    • F. Hoffmann-La Roche Ltd.
    • FUJIFILM Corporation
    • GE HealthCare Technologies Inc.
    • International Business Machines Corporation
    • Karkinos Healthcare Private Limited
    • McKesson Corporation
    • Medical Information Technology, Inc.
    • MICA Information Systems, Inc.
    • N-Power Medicine, Inc.
    • NextGen Healthcare, Inc.
    • Novarad Corporation
    • Oracle Corporation
    • RaySearch Laboratories
    • Royal Philips
    • Tempus AI, Inc.
    • Varian Medical Systems, Inc. by Siemens Healthineers AG
Product Code: MRR-0D217D5AE6B4

The Oncology Information Systems Market is projected to grow by USD 13.42 billion at a CAGR of 7.78% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.37 billion
Estimated Year [2025] USD 7.91 billion
Forecast Year [2032] USD 13.42 billion
CAGR (%) 7.78%

Navigating a transforming oncology information ecosystem driven by precision medicine, interoperability imperatives, and patient-centric digital care pathways

The oncology care continuum is being reshaped by converging technological, clinical, and regulatory forces that demand new forms of information management. Providers are balancing rising complexity in treatment regimens with an imperative to capture and harmonize multi-source clinical data, and as a result the role of oncology information systems has shifted from administrative enablers to strategic infrastructure. In this context, leaders must understand not only product capabilities but how systems integrate across care pathways, support multidisciplinary teams, and sustain long-term interoperability.

Clinicians and administrators are now asking for platforms that reduce cognitive load, accelerate decision making, and enable seamless data exchange across oncology-specific workflows and enterprise IT estates. As precision oncology expands, so too does the requirement for solutions that combine chemotherapy management, radiation planning, imaging integration, laboratory data, and longitudinal electronic health records into coherent user journeys. Consequently, investment decisions increasingly prioritize systems that demonstrate clinical efficacy, ease of integration, and measurable improvements in patient safety and operational efficiency.

This introduction frames the ensuing analysis by highlighting the strategic consequences of these trends for vendors, health systems, and policymakers. The focus that follows is practical and operational: identifying critical inflection points, examining segmentation-driven implications for product strategy, and outlining immediate actions that leaders can take to align technology adoption with patient-centered care objectives

Identifying transformative shifts reshaping oncology technology adoption including AI-enabled diagnostics, cloud-native architectures, and clinician workflow reengineering

The landscape of oncology information systems is experiencing transformative shifts that extend beyond incremental product enhancements to encompass new delivery models, analytic paradigms, and clinical workflows. Artificial intelligence and advanced visualization are moving into clinical practice, augmenting diagnostic confidence and helping prioritize cases, while clinical decision support is becoming more deeply embedded into treatment planning and scheduling to reduce variability and improve guideline adherence. Parallel to this, cloud-native deployments are accelerating, enabling distributed teams to access consolidated patient records and facilitating faster updates to clinical content and regulatory compliance modules.

Interoperability remains a central axis of change. New standards and APIs are lowering the barriers to connecting laboratory information systems, imaging archives, radiation planning software, and oncology electronic records into cohesive clinical flows. This shift encourages vendors to adopt modular, API-first architectures and to pursue partnerships with clinical integrators and imaging specialists. At the same time, workforce implications are profound: clinicians expect intuitive user interfaces that support multidisciplinary collaboration, and health systems are investing in training and change management to secure adoption and realize projected patient safety gains.

Taken together, these shifts are redefining vendor relevance and buyer expectations. Organizations that combine strong clinical validation, flexible deployment options, and clear implementation roadmaps will be best positioned to support evolving care models and to deliver measurable improvements in both clinical and operational outcomes

Assessing the cumulative operational and procurement impacts of United States tariff measures enacted in 2025 on oncology information system supply chains and services

Tariff measures introduced in the United States in 2025 have introduced a new variable into procurement and supply chain planning for oncology information system providers and their customers. While software is inherently portable, the broader value chain for oncology IT encompasses hardware, imaging equipment, specialized servers, and integration services that are sensitive to trade policy. As such, tariff-driven cost pressures have required procurement teams to re-evaluate vendor sourcing, total cost of ownership, and contingency strategies for equipment and service delivery.

Operationally, health systems and technology vendors have responded by diversifying supplier footprints and accelerating local sourcing for physical infrastructure where feasible. This has led to renewed emphasis on validating configurations that minimize dependence on tariff-exposed components, optimizing virtualized and cloud-hosted functions, and renegotiating service-level agreements to account for potential supply delays. In parallel, some vendors have adjusted commercial models to absorb part of the incremental burden through bundled service offerings, extended warranties, or localized installation teams.

Beyond immediate procurement tactics, tariffs have also influenced strategic conversations around manufacturing localization, contractual flexibility, and investment prioritization. Organizations are increasingly factoring supply chain resilience into vendor selection criteria, preferring partners that demonstrate transparent sourcing, robust logistics capabilities, and established contingency plans. These adaptations reflect a broader industry recognition that policy-driven cost dynamics can materially affect deployment timelines, project margins, and operational risk profiles

Translating segmentation intelligence into practical product and service strategies across offerings, functionalities, deployment modes, applications, and end user profiles

A nuanced understanding of segmentation is essential for aligning product development and go-to-market strategies with clinical and operational needs. Based on Offering, the landscape divides into Services and Solution, where Services include Consulting & Training, Installation & Integration, and Maintenance & Support, and Solution encompasses Chemotherapy Information System, Clinical Integration Solutions, Laboratory Information Systems (LIS), Medical Image Analysis & Advanced Visualization, Oncology Electronic Health Record (EHR), Picture Archiving & Communication System (PACS) & Vendor-Neutral Archive (VNA), Radiation Treatment Planning System, and Radiology Information Systems (RIS). This duality underscores that buyers are procuring bundles of functionality plus implementation expertise rather than standalone products.

Based on Functionality, offerings range from Billing & Revenue Cycle Management to Clinical Decision Support, Patient Information & Care Management, Regulatory Compliance & Reporting, and Treatment Planning & Scheduling, indicating that commercial success depends on addressing both administrative and high-acuity clinical workflows. Based on Deployment Mode, choices between Cloud-Based and On-Premise continuums influence procurement cadence, security posture, and integration complexity, and these options must be reflected in commercial and technical roadmaps.

Based on Application, differentiation across Medical Oncology, Radiation Oncology, and Surgical Oncology requires product teams to prioritize domain-specific workflows and decision support. Finally, Based on End User, solutions must account for the distinct needs of Ablation & Cancer Care Centers, Hospitals & Diagnostic Imaging Centers, and Research Facilities. In practice, successful strategies translate this segmentation into modular product architectures, configurable workflows, and services that reduce integration burden while delivering measurable clinician and operational value

Deciphering regional adoption patterns and strategic imperatives across the Americas, Europe, Middle East & Africa, and Asia-Pacific healthcare markets for oncology systems

Regional dynamics will increasingly dictate where and how oncology information systems are adopted, integrated, and scaled. In the Americas, health systems tend to prioritize interoperability with enterprise electronic health records, value-based care reporting, and advanced chemotherapy and radiation planning features, which drives demand for tightly integrated platforms and sophisticated clinical decision support. Procurement cycles in this region often emphasize contractual clarity, clinical validation, and demonstrable improvements in safety and throughput.

In Europe, Middle East & Africa, regulatory heterogeneity and diverse infrastructure maturity create opportunities for flexible deployment modes; cloud-based solutions can accelerate adoption in well-connected urban centers, while on-premise configurations remain important where data residency or bandwidth constraints persist. Regional priorities include harmonizing standards across health networks, supporting multilingual interfaces, and addressing local reimbursement and compliance frameworks.

In Asia-Pacific, rapid modernization of oncology services combined with significant private sector investment has spawned demand for scalable, cloud-enabled platforms and advanced imaging analytics. Markets in this region frequently value cost-effective, modular solutions that can be deployed quickly across multiple sites, alongside strong local implementation capabilities. Across all regions, successful vendors tailor propositions to local clinical practices, regulatory requirements, and procurement norms while supporting interoperability and clinician adoption through localized training and robust support models

Profiling competitive company behaviors and strategic moves that determine differentiation in oncology information systems including partnerships, integrations, and compliance focus

Company strategies in the oncology information systems space are converging on a few consistent themes: clinical validation, strategic partnerships, and platform extensibility. Leading vendors are investing in clinical studies and real-world evidence programs to demonstrate safety and workflow impact, while also seeking alliances with imaging specialists, laboratory providers, and systems integrators to deliver end-to-end solutions. At the same time, smaller, more agile companies are leveraging niche expertise in areas such as medical image analysis or radiation planning to gain footholds and to become attractive partners for larger platform vendors.

Commercial differentiation increasingly depends on the ability to provide certified interfaces and to support both cloud-based and on-premise deployments with clear security and compliance controls. Additionally, companies are refining pricing and service models to address the dual demands of capital-constrained providers and enterprise buyers seeking predictable operating costs. Talent acquisition and retention remain critical challenges; firms that can combine clinical informatics expertise with strong engineering teams will be better positioned to accelerate feature development and reduce time-to-deploy.

Mergers and partnerships continue to reshape competitive dynamics, but strategic success hinges on the ability to integrate disparate systems seamlessly, to back claims with clinical evidence, and to present a compelling value proposition to diverse end users including specialized cancer centers, hospital networks, and research institutions

Executive-level actionable recommendations to accelerate adoption, manage risk, and optimize commercial and clinical value from oncology information system investments

Industry leaders should adopt a prioritized, pragmatic set of actions that bridge clinical requirements and commercial viability. First, embed clinicians into product development cycles early and continuously, using structured clinical advisory boards and iterative usability testing to ensure that features align with real-world workflows and reduce cognitive burden. Second, adopt an API-first architecture and publish well-documented integration patterns to lower implementation friction and to enable faster interoperability with EHRs, LIS, PACS, and radiation planning tools.

Next, establish clear deployment playbooks that support both cloud-based and on-premise scenarios, including tested deployment templates, security baselines, and transition pathways for hybrid configurations. Invest in change management services-training, role-based learning pathways, and on-site support-to accelerate adoption and to secure measurable safety and efficiency outcomes. From a commercial perspective, consider offering outcome-linked service bundles or performance guarantees that align incentives with provider goals.

Finally, strengthen supply chain resilience by diversifying component sourcing, formalizing contingency plans, and offering transparent disclosure of sourcing and logistics. Governance and regulatory readiness should be continuous programs rather than discrete activities, and vendors should proactively engage with clinical and regulatory stakeholders to ease certification and compliance pathways. Taken together, these measures will materially reduce deployment risk and increase the likelihood of achieving sustained clinical and operational benefits

Outlining a rigorous mixed-methods research methodology combining primary stakeholder engagement, technical audits, and multi-source data triangulation for market evidence

The research underpinning this analysis combined mixed methods to ensure robustness and practical relevance. Primary research included structured interviews with clinicians, health system executives, IT leaders, and vendor product managers to capture firsthand perspectives on clinical workflow needs, procurement priorities, and implementation challenges. These conversations were supplemented by technical audits of representative solutions to evaluate integration architectures, security postures, and functional coverage across chemotherapy management, radiation planning, imaging, and laboratory interfaces.

Secondary research involved a systematic review of peer-reviewed clinical literature, regulatory guidance, standards documentation, and publicly available product specifications to contextualize vendor claims and to identify domain-specific best practices. Data triangulation was applied to reconcile differing viewpoints and to validate thematic findings across sources. Analytical methods included capability mapping against the defined segmentation framework, scenario analysis to stress-test supply chain and deployment assumptions, and gap analysis to highlight unmet clinical and operational needs.

Limitations are acknowledged: stakeholder perspectives reflect current adoption patterns and organizational priorities at the time of inquiry, and implementations can vary widely by institution. Nonetheless, the methodology prioritizes transparency, reproducibility, and practitioner validation to produce insights that are directly actionable for product, clinical, and commercial leaders

Concluding strategic synthesis that aligns clinical priorities, technology investments, and policy considerations to strengthen oncology information system outcomes and ROI

The synthesis of clinical priorities, technological capabilities, and policy drivers leads to a clear strategic imperative: oncology information systems must be both clinically intelligent and operationally adaptable. Stakeholders should prioritize solutions that demonstrate seamless interoperability across chemotherapy systems, radiation planning, imaging archives, laboratory data, and electronic records while also supporting advanced decision support, scheduling, and compliance workflows. Equally important is the need for flexible deployment models and service constructs that reduce implementation friction and support incremental rollouts.

Organizations that succeed will combine robust clinical validation, modular architectures, and strong local implementation capabilities to deliver measurable improvements in patient safety and care coordination. Supply chain resilience and procurement agility have emerged as additional differentiators, particularly in environments affected by policy-driven cost pressures. Finally, the pursuit of clinician-centric design and continuous performance monitoring will determine adoption and long-term value realization. This conclusion underscores an actionable focus: align investments with demonstrable clinical outcomes, prioritize interoperability, and institutionalize governance to sustain performance over time

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. AI-driven predictive analytics integration in oncology information systems for personalized treatment planning
  • 5.2. Integration of comprehensive genomic sequencing data into oncology information platforms for precision medicine
  • 5.3. Cloud-based oncology information systems enabling secure remote collaboration across multidisciplinary care teams
  • 5.4. Implementation of HL7 FHIR interoperability standards for seamless oncology data exchange and reporting
  • 5.5. Advanced patient-reported outcome tracking modules for real-time quality-of-life insights in cancer care
  • 5.6. Machine learning algorithms predicting adverse drug reactions from electronic oncology records for improved safety monitoring
  • 5.7. Teleoncology virtual care integration in oncology information systems to expand rural patient access and support

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Oncology Information Systems Market, by Offering

  • 8.1. Services
    • 8.1.1. Consulting & Training
    • 8.1.2. Installation & Integration
    • 8.1.3. Maintenance & Support
  • 8.2. Solution
    • 8.2.1. Chemotherapy Information System
    • 8.2.2. Clinical Integration Solutions
    • 8.2.3. Laboratory Information Systems (LIS)
    • 8.2.4. Medical Image Analysis & Advanced Visualization
    • 8.2.5. Oncology Electronic Health Record (EHR)
    • 8.2.6. Picture Archiving & Communication System (PACS) & Vendor-Neutral Archive (VNA)
    • 8.2.7. Radiation Treatment Planning System
    • 8.2.8. Radiology Information Systems (RIS)

9. Oncology Information Systems Market, by Functionality

  • 9.1. Billing & Revenue Cycle Management
  • 9.2. Clinical Decision Support
  • 9.3. Patient Information & Care Management
  • 9.4. Regulatory Compliance & Reporting
  • 9.5. Treatment Planning & Scheduling

10. Oncology Information Systems Market, by Deployment Mode

  • 10.1. Cloud-Based
  • 10.2. On-Premise

11. Oncology Information Systems Market, by Application

  • 11.1. Medical Oncology
  • 11.2. Radiation Oncology
  • 11.3. Surgical Oncology

12. Oncology Information Systems Market, by End User

  • 12.1. Ablation & Cancer Care Centers
  • 12.2. Hospitals & Diagnostic Imaging Centers
  • 12.3. Research Facilities

13. Oncology Information Systems Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Oncology Information Systems Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Oncology Information Systems Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Accuray Incorporated
    • 16.3.2. Advanced Data Systems Corporation
    • 16.3.3. CompuGroup Medical, Inc.
    • 16.3.4. CureMD.com, Inc.
    • 16.3.5. DOSIsoft SA
    • 16.3.6. Elekta AB
    • 16.3.7. EndoSoft LLC by Utech Products Inc.
    • 16.3.8. Epic Systems Corporation
    • 16.3.9. F. Hoffmann-La Roche Ltd.
    • 16.3.10. FUJIFILM Corporation
    • 16.3.11. GE HealthCare Technologies Inc.
    • 16.3.12. International Business Machines Corporation
    • 16.3.13. Karkinos Healthcare Private Limited
    • 16.3.14. McKesson Corporation
    • 16.3.15. Medical Information Technology, Inc.
    • 16.3.16. MICA Information Systems, Inc.
    • 16.3.17. N-Power Medicine, Inc.
    • 16.3.18. NextGen Healthcare, Inc.
    • 16.3.19. Novarad Corporation
    • 16.3.20. Oracle Corporation
    • 16.3.21. RaySearch Laboratories
    • 16.3.22. Royal Philips
    • 16.3.23. Tempus AI, Inc.
    • 16.3.24. Varian Medical Systems, Inc. by Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ONCOLOGY INFORMATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ONCOLOGY INFORMATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CONSULTING & TRAINING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CHEMOTHERAPY INFORMATION SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL INTEGRATION SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL IMAGE ANALYSIS & ADVANCED VISUALIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ONCOLOGY ELECTRONIC HEALTH RECORD (EHR), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) & VENDOR-NEUTRAL ARCHIVE (VNA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION TREATMENT PLANNING SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS (RIS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY BILLING & REVENUE CYCLE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY PATIENT INFORMATION & CARE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE & REPORTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY TREATMENT PLANNING & SCHEDULING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY MEDICAL ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RADIATION ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SURGICAL ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY ABLATION & CANCER CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY RESEARCH FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY FUNCTIONALITY, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY OFFERING, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA ONCOLOGY INFORMATION SYSTEMS MARKET SIZE, BY SOLUTION, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA ONCOLOGY INFORMATION SYSTEM